Priosh has entered into a strategic partnership with Shankus Hospitals Pvt Ltd, a group of 10+ hospitals, recognized as a leading center for cancer treatment, to develop a state-of-the-art biorepository. This facility is pivotal in the collection, storage, and translational research of various biospecimens, including blood, tissue, and other bodily fluids, derived from patients of the hospital’s specialized oncology department. Each year, a single medical center within this network handles tens of thousands of patients, a number that continues to rise. At Shankus Hospitals, a multidisciplinary team of experienced oncologists, surgeons, and support staff leverage advanced medical technology to diagnose, treat, and manage a wide spectrum of cancer cases, ensuring the highest standards of care. Adhering to rigorous protocols, the biorepository ensures the quality, traceability, and integrity of each sample. These samples, sourced from both patients undergoing treatment and healthy research participants, are collected and handled in strict compliance with ethical standards, safeguarding patient privacy and confidentiality. This collaboration aims to enhance medical research capabilities and foster the development of new diagnostic tools and treatments, ultimately improving patient outcomes.